Sponsor Pipeline

GV20 Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07623642 A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in… Uterine Cervical Neoplasms Not Yet Recruiting
Phase 1/2
NCT05669430 A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in… Solid Tumor, Adult Recruiting
NCT07070518 Study of GV20-0251 in Participants With Solid Tumor Malignancies Solid Tumor Cancer Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3) Endometrial Cancer (2) Melanoma (2) Small Cell Lung Cancer (2) Liver Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Bladder Cancer (1)
Get alerts when GV20 Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free